Singapore Eye Research Institute Performs Breakthrough Research On Chronic Inflammatory Eye Conditions With AB SCIEX TripleTOF™ 5600 System

by Medical News Today • 2011/04/20 • 0 Comments

AB SCIEX, a global leader in life science analytical technologies, today announced that the Singapore Eye Research Institute (SERI), an internationally known eye research center, will advance biomarker candidates it identified for chronic inflammatory eye conditions into large-scale clinical trials for validation with the AB SCIEX TripleTOF™ 5600 System...

← National Innovative Vision Research Award To Be Presented To IUPUI Faculty Member

LensAR Focuses On $2M of $7M Offering for Laser 3D Imaging Tech →

Post navigation